Johnson & Johnson’s Kenvue IPO Eyes Whopping $3 Billion Boost – Excitement Builds!
Pharmaceutical giant Johnson & Johnson (J&J) has announced its intentions to raise around $3 billion in an initial public offering (IPO) of its consumer-health unit. In a recent filing with the Securities and Exchange Commission, J&J disclosed that it expects to sell over 151 million shares in the IPO at a price range of $20 […]